Chat with us

Export Guidelines: Imfinzi 120ml USA | Ernest Impex Global Supplier

Imfinzi 120ml Injection (Durvalumab) Global Supply & Clinical Profile

Looking for a trusted global partner for high-quality oncology medications? Ernest Impex, a premier pharmaceutical exporter from India and a part of the Ernest Pharmaceutical Pvt. Ltd. group, specializes in the bulk supply and export of life-saving treatments. We bridge the gap between high-quality Indian pharmaceuticals and global healthcare systems, ensuring that critical oncology medicines, including Imfinzi 120 ml Injection, reach hospitals, pharmacies, and healthcare providers worldwide, including in Washington, London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).

🏥 Clinical Overview: Understanding Imfinzi 120ml Injection

Imfinzi 120ml Injection contains Durvalumab, a human monoclonal antibody designed to combat specific types of advanced cancers. It belongs to a class of medications called checkpoint inhibitors.

Durvalumab works by targeting the PD-L1 pathway, which tumors often use to evade detection by the immune system. By blocking this interaction, the medication enables the patient's immune system to recognize, target, and destroy malignant cells effectively.

Core Indications

Imfinzi is primarily indicated for the treatment of the following:

Stage III Non-Small Cell Lung Cancer (NSCLC): Used in patients whose disease has not progressed following chemoradiation therapy.
Small Cell Lung Cancer (SCLC): In combination with chemotherapy as a first-line treatment.
Biliary Tract Cancer: In combination with gemcitabine and cisplatin for advanced or unresectable cases.
Hepatocellular Carcinoma (HCC): For the treatment of liver cancer.

⚙️ Mechanism of Action

Imfinzi utilizes a targeted immunological approach to halt tumor progression. Its mechanism involves:

PD-L1 Binding Blockade: Durvalumab selectively binds to the PD-L1 protein, preventing its interaction with both PD-1 and CD80 receptors on the T-cells.
T-Cell Reinvestment: By blocking this inhibitory signal, the drug restores the anti-tumor activity of T-cells.
Immune System Activation: It allows the patient’s own immune system to identify and attack cancer cells, limiting tumor growth and metastasis.

❄️ Storage and Handling Requirements

To maintain the efficacy, stability, and sterility of the Imfinzi 120 ml injection, strict cold-chain and storage guidelines must be observed:

Temperature Control: Store in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Do Not Freeze: Freezing can denature the monoclonal antibody structure, rendering it ineffective.
Preparation and Dilution: The vial must not be shaken. Once diluted for intravenous infusion, it should be administered immediately or stored at specific refrigerated temperatures according to the product monograph.

🤝 Why Choose Ernest Impex?

Verified Quality: All products are sourced from GMP-certified facilities.
Logistics Expertise: Seamless customs clearance, cold chain maintenance, and reliable door-to-door delivery.
Competitive Pricing: Direct-from-source pricing for hospitals and bulk buyers.
Export Responsibility: Ernest Impex manages the entire global supply and export process directly from India. You do not need to worry about the export process; all logistics, customs, and cold-chain integrity are handled by our expert team.

📋 PRESCRIPTION MEDICINE IS YES

⚠️ Short Disclaimer

Imfinzi (Durvalumab) is a prescription-only oncology medication. It must be administered strictly under the supervision of qualified healthcare professionals and oncologists. Patients must adhere to all safety protocols and monitoring guidelines established by regulatory authorities in their respective regions.